These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26412695)

  • 1. Validation Studies for Microbial Contamination and Control of Contaminants.
    Shintani H
    Biocontrol Sci; 2015; 20(3):161-70. PubMed ID: 26412695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Microbiological in-process control in drug manufacture].
    Seyfarth VH
    Arzneimittelforschung; 1985; 35(1A):205-16. PubMed ID: 4039162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial identification strategies in the pharmaceutical industry.
    Cundell AM
    PDA J Pharm Sci Technol; 2006; 60(2):111-23. PubMed ID: 16696194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of different incubation conditions for microbiological environmental monitoring.
    Gordon O; Berchtold M; Staerk A; Roesti D
    PDA J Pharm Sci Technol; 2014; 68(5):394-406. PubMed ID: 25336415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation Study of Rapid Assays of Bioburden, Endotoxins and Other Contamination.
    Shintani H
    Biocontrol Sci; 2016; 21(2):63-72. PubMed ID: 27350424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation study on how to avoid microbial contamination during pharmaceutical production.
    Shintani H
    Biocontrol Sci; 2015; 20(1):1-10. PubMed ID: 25817807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous Microbiological Environmental Monitoring for Process Understanding and Reduced Interventions in Aseptic Manufacturing.
    Weber J; Hauschild J; Ijzerman-Boon P; Forng RY; Horsch J; Yan L; Prasad A; Henry RB; Claassen M; Villari P; Shereefa S; Wyatt J; Bolden JS; Pycke JT; Dassu D
    PDA J Pharm Sci Technol; 2019; 73(2):121-134. PubMed ID: 30361285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbial diversity in pharmaceutical product recalls and environments.
    Jimenez L
    PDA J Pharm Sci Technol; 2007; 61(5):383-99. PubMed ID: 18047177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contamination Control.
    Akers MJ
    Int J Pharm Compd; 2015; 19(3):232-8. PubMed ID: 26714364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biotest RCS air samplers in unidirectional flow.
    Ljungqvist B; Reinmüller B
    J Pharm Sci Technol; 1994; 48(1):41-4. PubMed ID: 8004418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host cell proteins in biotechnology-derived products: A risk assessment framework.
    de Zafra CL; Quarmby V; Francissen K; Vanderlaan M; Zhu-Shimoni J
    Biotechnol Bioeng; 2015 Nov; 112(11):2284-91. PubMed ID: 26010760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Charting and Evaluation of Environmental Microbial Monitoring Data.
    Bar R
    PDA J Pharm Sci Technol; 2015; 69(6):743-61. PubMed ID: 26659105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Points to Consider: Best Practices to Identify Particle Entry Routes along the Manufacturing Process for Parenteral Formulations.
    Anger S; Begat C; Crnko V; Fantozzi G; Farach W; Fitzpatrick S; Gallagher B; Huelsmann S; Kinsey P; Langlade V; Lefevre G; Legendre E; McLean K; Miller J; Patel R; Perry A; Soukiassian H; Stanton A; Streich D; Timmons C; Vaneylen D; van Hoose T; Wildling L; Windover M
    PDA J Pharm Sci Technol; 2019; 73(6):635-647. PubMed ID: 31420504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiological testing of pharmaceuticals and cosmetics in Egypt.
    Zeitoun H; Kassem M; Raafat D; AbouShlieb H; Fanaki N
    BMC Microbiol; 2015 Dec; 15():275. PubMed ID: 26653032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative Microbial Risk Assessment of Pharmaceutical Products.
    Eissa ME
    PDA J Pharm Sci Technol; 2017; 71(3):245-251. PubMed ID: 27974628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revision of Viable Environmental Monitoring in a Development Pilot Plant Based on Quality Risk Assessment: A Case Study.
    Ziegler I; Borbély-Jakab J; Sugó L; Kovács RJ
    PDA J Pharm Sci Technol; 2017; 71(3):234-244. PubMed ID: 28089966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extractables from integrated single-use systems in biopharmaceutical manufacturing. Part I. Study on components (Pall Kleenpak connector and Kleenpak filter capsule).
    Ding W; Nash R
    PDA J Pharm Sci Technol; 2009; 63(4):322-38. PubMed ID: 20088246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between air movements and the dispersion of contaminants: clean zones with unidirectional air flow.
    Ljungqvist B; Reinmüller B
    J Parenter Sci Technol; 1993; 47(2):60-9. PubMed ID: 8515346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viruses and assuring viral safety.
    Robertson JS
    Dev Biol (Basel); 2003; 113():73-7. PubMed ID: 14620855
    [No Abstract]   [Full Text] [Related]  

  • 20. The promise of molecular imprinting.
    Mosbach K
    Sci Am; 2006 Oct; 295(4):86-91. PubMed ID: 16989485
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.